PG11 - Clinical highlights on tuberculosis

Postgraduate Course
Chairs: L. Casali (Terni, Italy), P. D. O. Davies (Liverpool, United Kingdom)
Aims: This course is designed to offer an updated view on new and old scenarios starting from a clinical point of view. At the end of the course participants will:
• be able to recognize the clinical characteristics of TB both in normal and in compromised patients;
• be updated on knowledge of the optimal moments to start and to finish treatment. Target audience: Pneumologists, clinical-pharmacologists, GPs, nurses, paediatricians and pharmacologists.

Latent tuberculosis in the nonimmunocompromised host T. Schaberg (Rotenburg, Germany)
Tuberculosis in the immunocompromised host: atypical TB? P. D. O. Davies (Liverpool, United Kingdom)
The clinical and bacteriological basis for initiating a specific treatment J-P. Zellweger (Lausanne, Switzerland)
When may it be correct to stop the treatment? A clinical, bacteriological and radiological task P. Kelly (Dublin, Ireland)